Reviva to participate in the lytham partners 2025 investor healthcare summit

Cupertino, calif., jan. 07, 2025 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), inflammatory and cardiometabolic diseases, today announced that laxminarayan bhat, ph.d., founder, president, and ceo of reviva will participate in a webcasted presentation at the lytham partners 2025 investor healthcare summit, taking place virtually on monday, january 13, 2025.
RVPH Ratings Summary
RVPH Quant Ranking